← Open Payments lookup

KIMBERLY BERENBAUM: Open Payments

NPI 1760101182 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,317 in 25 payments from 7 companies in 2025. Trend: 2023 $746 · 2024 $879 · 2025 $1,317

Food & beverage: $1,233Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.5$614
ABBVIE INC.12$194
Aimmune Therapeutics, Inc.2$139
GlaxoSmithKline, LLC.1$118
Takeda Pharmaceuticals U.S.A., Inc.1$99
Intercept Pharmaceuticals, Inc.1$97
PFIZER INC.3$58

Products named: TREMFYA, ZENPEP, AREXVY, OCALIVA, VELSIPITY, RINVOQ, CREON, LINZESS.

Industry payments across PA — which companies pay providers there.